Models that Lanli Biology has established and verified:
1. Subcutaneous Inoculation Model
|
Tumor type
|
Model
|
|
Bladder
|
5637，HT1376，RT4，RT112/84，UM-UC-1
|
|
Blood/Leukemia
|
ARH-77，EOL-1，HL-60，Jurkat clone E6-1，JVM-3，K-562，Kasumi-1，L-363，ML-2， MOLM-13，MOLM-16，MOLT-4，MV-4-11，NALM-6，RS4;11，THP-1，KG-1 ,PEER
|
|
Blood/Lymphoma
|
CA46，Daudi，DOHH-2，GRANTA-519，JeKo-1，KARPAS-299，KARPAS-422，NAMALWA，OCI-LY19，OCI-LY7，Pfeiffer，Raji，Ramos，RL，SU-DHL-1，SU-DHL-2，SU-DHL-6，SU-DHL-8， SU-DHL-10，U-937，WSU-DLCL2，Z-138，HUT102，L-540
|
|
Blood/Myeloma
|
AMO-1，MM.1R，MM.1S，MOLP8，NCI-H929，OPM2，RPMI 8226，U266B1，JJN-3
|
|
Bone
|
143B，SJSA-1，SK-ES-1
|
|
Brain&Nerves
|
LN-229，SF268，U-118 MG，U-87 MG，IMR-32
|
|
Breast
|
BT-474，DU4475，HCC1954，JIMT-1，MCF7，MX-1，ZR-75-1，HCC1806，HCC1187，HCC1569，T47D， MDA-MB-231，MDA-MB-134，MDA-MB-468，MAD-MB-436，MDA-MB-435
|
|
Head&Neck
|
KYSE-150，KYSE-270，KYSE-410，OE19，C666-1，FaDu，CAL-27，SCC-4，Detroit562，EC109, T.T，TT
|
|
Kidney
|
786-O，A498，Caki-1
|
|
Colorectum
|
COLO 205，COLO 320DM，DLD-1，HCT 116，HCT-15，HT-29，LoVo，LS 174T，LS411N，RKO，SNU-81，SW48，SW480，SW620，SW948，T84，SW837，HT55，KM12L4，NCI-H716
|
|
Liver
|
HCCLM3，HEP G2，HEP G2/C3A，HEP3B，HUH-1，HUH-7，JHH-5，JHH-7，MHCC97-H，PLC/PRF/5， SK-HEP-1，SNU-761，SNU-878，HUCCT1
|
|
Lung
|
A549，CALU-3，CALU-6，COR-L23，DMS 114，EBC-1，H69AR，HCC1359，HCC4006，HCC827，HCC827-ER1， NCI-H1048，NCI-H1155，NCI-H1299，NCI-H1417，NCI-H146，NCI-H1581，NCI-H1650，NCI-H1703，NCI-H1781， NCI-H1975，NCI-H1993，NCI-H2023，NCI-H209，NCI-H2110，NCI-H2122，NCI-H2228，NCI-H292，NCI-H358， NCI-H441，NCI-H446，NCI-H460，NCI-H520，NCI-H526，NCI-H568，NCI-H69，NCI-H727，NCI-H82，NCI-H820， NCI-H838，NCI-H889，PC-9，RERF-LC-A1，RERF-LC-AD1，SK-MES-1，SNU-2535，MSTO 211H，NCI-H226
|
|
Ovary
|
A2780，ES-1，IGR-OV1，OVCAR-3，OVCAR-8，PA-1，RMG-1，SK-OV-3，TOV112D，TOV-21G
|
|
Pancreas
|
AsPC-1，BxPC-3，Capan-1，Capan-2，HPAC，HPAF-II，Hs766T，HUP-T3，KP4，MIA PaCa-2，PANC-1， PANC 02.13，PANC 03.27，PANC 05.04
|
|
Skin
|
A2058，A-375，A-431，SK-MEL-28，SK-MEL-5，MeWo
|
|
Gastric
|
HGC-27，HS 746.T，MKN45，NCI-N87，NUGC-4，SNU-5，SNU-16，YCC-2，YCC-10，SNU601，SNU620
|
|
Uterus
|
AN3 CA，Ishikawa
|
|
Prostate
|
22RV1，C4-2，DU 145，LNCaP clone FGC，NCI-H660，PC-3，PC-3M，VCAP
|
|
Other
|
HT1080，NCI-H295R，A-673，JEG-3，HeLa，SiHa
|
2. Luciferase-labeled CDX model
SK-OV-3-Luc，Nalm6-Luc，Nalm6-Luc-CD19 KO，Nalm6-Luc-CD22 KO，Nalm6-Luc-CD19/CD22 KO，Raji-Luc，Raji -PDL1-Luc， Raji-Luc-CD19 KO，Raji-Luc-CD22 KO，Raji-Luc-CD19/CD22 KO，MV-4-11 Luc，MM.1S-Luc，MCF7-Luc，JeKo-1-Luc，HUH-7 Luc，A549Luc，DU 145 Luc2，DU 145 Luc hGDF-15FL，DU 145 Luc hGDF-15MP， RPMI-8226-Luc，U87-MG-Luc
3. In situ inoculation model, transfer model, etc.
Lanli Biology also provides in situ models, leukemia systemic tumor models, tumor metastasis models, and genetically modified tumor models. Please consult for details.info@lanlybio.com。
